Our results showed that TRIM65 relieved G2/M phase cell cycle arrest and increased the protein levels of CyclinD1, indicating that TRIM65 regulates the RCC cell cycle through BTG3-CyclinD1 axis. The gene discussed is BTG3; the disease is renal cell carcinoma.